Looking to publish in Transplantation and Cellular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTransplantation and Cellular Therapy is the official publication of the American Society for Transplantation and Cellular Therapy and focuses on the interdisciplinary field of hematopoietic cell transplantation and cellular therapies. The journal emphasizes clinical care, treatment outcomes, standards, best practices, evidence-based approaches, current technology, groundbreaking research, and clinical applications. It publishes original research reports, practice guidelines, reviews, editorials, commentaries, and letters to the editor.
Looking to publish in Transplantation and Cellular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Transplantation and Cellular Therapy accepts the following article types. Click on an article type to view submission instructions.
Regular Manuscripts
Review Articles
Clinical Reviews
Research Communications
Letters
Recent Publications
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
Uday R. Popat, Konstantinos Lontos, Roland Bassett, Jitesh Kawedia, Ben C. Valdez, Alison M. Gulbis, Amin M. Alousi, Gheath Al-Atrash, Qaiser Bashir, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, Issa Khouri, David Marin, Rohtesh S. Mehta, Yago Nieto, Betul Oran, Amanda Olson, Muzaffar H. Qazilbash, Jeremy Ramdial, Neeraj Saini, Samer A. Srour, Tapan Kadia, Naval Daver, Nicholas J. Short, Katayoun Rezvani, Guillermo Garcia-Manero, Richard E. Champlin, Borje S. Andersson, Elizabeth J. Shpall
Impact of Bridging Response on Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma
Beatriz Wills, Sarah Samorodnitsky, Samantha Brown, Jessica R. Flynn, Sean Devlin, Michael Scordo, Sandeep Raj, Karthik Nath, Gunjan L. Shah, Juliana Castro, Jennifer E. Liu, Heiko Schoder, Burcin Agridag Ucpinar, Akshay Bedmutha, Ofrat Beyar-Katz, Iris Halamish, Andrew Ip, Brandon Imber, Sergio Giralt, Miguel-Angel Perales, Gilles Salles, Roni Shouval, M. Lia Palomba
T-Cell Lymphoma Associated with CAR-T Cell Therapy: A Bayesian Disproportionality Analysis of a National Database
Connor Frey
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective Analysis
Alexandre Chevalier, Baptiste Bonneau, Lea Grote-Levi, Nora Möhn, Paola Cinque, Jeremy D. Rubinstein, Rebecca Wicklein, Thomas Pfeiffer, Bilal Omer, Maximilian Steinhardt, Jean-Jacques Tudesq, Nathalie Testard, Patrice Chevallier, Raphael Bernard-Valnet, Marion Le Maréchal, Gaia Catalano, Béatrice Pignolet, Agnès Sommet, Britta Eiz-Vesper, Patrizia Comoli, Thomas Skripuletz, Irene Cortese, Daniele Bensoussan, Guillaume Martin-Blondel
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapies.
Agrima Mian, Rafaella Litvin, Danai Dima, Betty K. Hamilton, Allison Winter, Jack Khouri, Louis Williams, Shahzad Raza, Deepa Jagadeesh, Aaron T. Gerds, Robert M. Dean, Ronald M. Sobecks, Faiz Anwer, Matt E. Kalaycio, Claudio G. Brunstein, Craig S. Sauter, Marcelo Pasquini, Brian T. Hill, Paolo F. Caimi
Frequently asked questions
How long does it take to publish?
3 days from submission to first decision; 29 days from submission to decision after review; 74 days from submission to acceptance; 5 days from acceptance to online publication.
Reformat to Transplantation and Cellular Therapy using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should identify the corresponding author’s name, address, phone number, fax number, and e-mail address, specify the manuscript category and word count, include prior peer review information for Fast Track submissions, and indicate willingness to pay extra costs for color photographs when applicable.
Reformat to Transplantation and Cellular Therapy using Livewrite PremiumWhat are the publication costs?
Open access APC is USD 4000 excluding taxes for all articles. Subscription publication has no open access publication fee.
Reformat to Transplantation and Cellular Therapy using Livewrite Premium